Effects of Triflusal and Clopidogrel in Secondary Prevention of Stroke Based on Cytochrome P450 2C19 Genotyping

被引：0
|
作者：
Lee, Kyung-Yul
Han, Sang Won
Kim, Yong-Jae
Ahn, Seong Hwan
Seo, Woo-Keun
Yu, Sungwook
Oh, Seung-Hun
Kim, Youn Nam
机构：
来源：
STROKE | 2017年 / 48卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
ATP411
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Catalytic enhancements in cytochrome P450 2C19 by cytochrome b5
    Lee, Gyu-Hyeong
    Kim, Vitchan
    Lee, Sung-Gyu
    Jeong, Eunseo
    Kim, Changmin
    Lee, Yoo-Bin
    Kim, Donghak
    TOXICOLOGICAL RESEARCH, 2024, 40 (02) : 215 - 222
  • [32] CYTOCHROME P450 2C19 POLYMORPHISM IN ACUTE ISCHEMIC STROKE IN NORTH-WEST OF IRAN
    Faroudi, M.
    Hokmabadi, E. Sadeghi
    Mehdizadehfar, E.
    Sadeghpour, Y.
    Sakhinia, E.
    Rahnemayan, S.
    Taheraghdam, A.
    INTERNATIONAL JOURNAL OF STROKE, 2024, 19 (02) : 395 - 395
  • [33] Biological effect of increased maintenance dose of clopidogrel in cardiovascular outpatients and influence of the cytochrome P450 2C19*2 allele on clopidogrel responsiveness
    Fontana, Pierre
    Senouf, David
    Mach, Francois
    THROMBOSIS RESEARCH, 2008, 121 (04) : 463 - 468
  • [34] GENETIC POLYMORPHISM OF CYTOCHROME P450 (2C19) IN PATIENTS WITH RENAL TRANSPLANT
    Ciftci, Hayriye Senturk
    Tefik, Tzevat
    Turkmen, Aydin
    Nane, Ismet
    Oguz, Fatma Savran
    Aydin, Filiz
    TISSUE ANTIGENS, 2014, 84 (01): : 58 - 59
  • [35] Effects of Cytochrome P450 2C19 and Paraoxonase 1 Polymorphisms on Antiplatelet Response to Clopidogrel Therapy in Patients with Coronary Artery Disease
    Tresukosol, Damrus
    Suktitipat, Bhoom
    Hunnangkul, Saowalak
    Kamkaew, Ruttakarn
    Poldee, Saiphon
    Tassaneetrithep, Boonrat
    Likidlilid, Atip
    PLOS ONE, 2014, 9 (10):
  • [36] Voriconazole Metabolism, Toxicity, and the Effect of Cytochrome P450 2C19 Genotype
    Zonios, Dimitrios
    Yamazaki, Hiroshi
    Murayama, Norie
    Natarajan, Ven
    Palmore, Tara
    Childs, Richard
    Skinner, Jeff
    Bennett, John E.
    JOURNAL OF INFECTIOUS DISEASES, 2014, 209 (12): : 1941 - 1948
  • [37] Cost-Effectiveness of Cytochrome P450 2C19 Genotype Screening for Selection of Antiplatelet Therapy with Clopidogrel or Prasugrel
    Reese, Emily S.
    Mullins, C. Daniel
    Beitelshees, Amber L.
    Onukwugha, Eberechukwu
    PHARMACOTHERAPY, 2012, 32 (04): : 323 - 332
  • [38] Cytochrome P450 2C19 Inhibitory Activity of Common Berry Constituents
    Sand, Philipp G.
    Dreiseitel, Andrea
    Stang, Martin
    Schreier, Peter
    Oehme, Anett
    Locher, Sanja
    Hajak, Goeran
    PHYTOTHERAPY RESEARCH, 2010, 24 (02) : 304 - 307
  • [39] Cytochrome P450 2C19 polymorphism and cardiovascular recurrences in patients under clopidogrel treatment: a meta-analysis
    Sofi, F.
    Giusti, B.
    Gori, A.
    Marcucci, R.
    Abbate, R.
    Gensini, G.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 : 105 - 105
  • [40] Metabolism of testosterone and progesterone by cytochrome P450 2C19 allelic variants
    Takeji, Shiori
    Okada, Mai
    Hayashi, Shu
    Kanamaru, Kengo
    Uno, Yuichi
    Imaishi, Hiromasa
    Uno, Tomohide
    BIOPHARMACEUTICS & DRUG DISPOSITION, 2023, 44 (06) : 420 - 430
12345